These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26492885)

  • 21. Methyltransferase of a cell culture-adapted hepatitis E inhibits the MDA5 receptor signaling pathway.
    Myoung J; Lee JY; Min KS
    J Microbiol; 2019 Dec; 57(12):1126-1131. PubMed ID: 31758397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis E virus inhibits type I interferon induction by ORF1 products.
    Nan Y; Yu Y; Ma Z; Khattar SK; Fredericksen B; Zhang YJ
    J Virol; 2014 Oct; 88(20):11924-32. PubMed ID: 25100852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis E Virus Mutations: Functional and Clinical Relevance.
    van Tong H; Hoan NX; Wang B; Wedemeyer H; Bock CT; Velavan TP
    EBioMedicine; 2016 Sep; 11():31-42. PubMed ID: 27528267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
    Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
    Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of epidermal growth factor receptor signaling favors hepatitis E virus life cycle.
    Woytinek K; Glitscher M; Hildt E
    J Virol; 2024 Jul; 98(7):e0058024. PubMed ID: 38856640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOCS3 Drives Proteasomal Degradation of TBK1 and Negatively Regulates Antiviral Innate Immunity.
    Liu D; Sheng C; Gao S; Yao C; Li J; Jiang W; Chen H; Wu J; Pan C; Chen S; Huang W
    Mol Cell Biol; 2015 Jul; 35(14):2400-13. PubMed ID: 25939384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
    Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of PI3K-PKB-mTOR pathway.
    Zhou X; Wang Y; Metselaar HJ; Janssen HL; Peppelenbosch MP; Pan Q
    J Hepatol; 2014 Oct; 61(4):746-54. PubMed ID: 24859454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.
    Hsu SF; Su WC; Jeng KS; Lai MM
    J Virol; 2015 Apr; 89(7):3671-82. PubMed ID: 25589657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replication.
    Debing Y; Winton J; Neyts J; Dallmeier K
    Antiviral Res; 2013 Oct; 100(1):98-101. PubMed ID: 23916729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.
    Ito M; Masumi A; Mochida K; Kukihara H; Moriishi K; Matsuura Y; Yamaguchi K; Mizuochi T
    J Innate Immun; 2010; 2(6):607-17. PubMed ID: 20714117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Interplay between Host Innate Immunity and Hepatitis E Virus.
    Li Y; Qu C; Yu P; Ou X; Pan Q; Wang W
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31212582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
    Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
    Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
    Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
    Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient.
    Kamar N; Abravanel F; Garrouste C; Cardeau-Desangles I; Mansuy JM; Weclawiak H; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2010 Aug; 25(8):2792-5. PubMed ID: 20494897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopathogenesis of hepatitis E virus infection.
    Wedemeyer H; Rybczynska J; Pischke S; Krawczynski K
    Semin Liver Dis; 2013 Feb; 33(1):71-8. PubMed ID: 23564391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
    Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
    Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein phosphatase PP1 negatively regulates the Toll-like receptor- and RIG-I-like receptor-triggered production of type I interferon by inhibiting IRF3 phosphorylation at serines 396 and 385 in macrophage.
    Gu M; Zhang T; lin W; Liu Z; Lai R; Xia D; Huang H; Wang X
    Cell Signal; 2014 Dec; 26(12):2930-9. PubMed ID: 25239187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.